With several of these drugs going off patent in the next few years, OneSource is poised to see big growth in the generic ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

That, according to the firm, make them particularly suitable for users of GLP-1 medications. GLP-1 drugs such as Ozempic and ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

At Institute for Healthcare Improvement meeting, Parkview Health’s Jeffrey Boord, M.D., M.P.H., explained why enhanced ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

Eli Lilly ( LLY -1.72%) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...